Product Information

ATORVASTATIN 80 MG TABLET is a generic product labeled by Quallent Pharmaceuticals Health LLC, priced at $0.0692 per EA under NDC 82009017910. Its NADAC has been published 42 times since Nov 5, 2025.

FDA first approved this application on Sep 12, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The Low Outlier badge above means this manufacturer's average price in the ATORVASTATIN CALCIUM market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Price Statistics

The NADAC for ATORVASTATIN 80 MG TABLET has been published 42 times since Nov 5, 2025, and over the history we have for it it has declined 2.9%. The table below summarizes its recorded NADAC range and movement.

Generic Alternatives

The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.